{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-045420","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2023-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.431689+00:00","generated_at":"2026-06-07T10:53:00.522065+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Mangoceuticals raises $1.2M in public offering of 4M shares at $0.30 per share","bullets":["Priced public offering of 4,000,000 shares at $0.30 per share for gross proceeds of $1,200,000.","Closed on Dec 19, 2023; net proceeds approximately $1.0 million after underwriting discounts and expenses.","Granted underwriter Boustead Securities a warrant to purchase 280,000 shares at $0.38, exercisable until Dec 14, 2029.","Proceeds to fund marketing of Mango ED and GROW hair growth products, hiring, software development, and working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-045420","json":"https://secwatch.observer/filing/0001493152-23-045420.json","markdown":"https://secwatch.observer/filing/0001493152-23-045420.md","text":"https://secwatch.observer/filing/0001493152-23-045420.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315223045420/0001493152-23-045420-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315223045420/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T10:53:00.522065+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8a6b3a0353048a2b76d1756ce9d3ef1a42956359","claim":"MANGOCEUTICALS, INC. entered into Underwriting Agreement with Boustead Securities, LLC, as representative of the underwriters valued at $1.2 million (effective 2023-12-15).","evidence_excerpt":"On December 15, 2023, Mangoceuticals, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Boustead Securities, LLC, as representative (the “ Representative ”) of the underwriters named on Schedule 1 thereto (the “ Underwriters ”), relating to a public offering of the Company’s common stock (the “ Offering ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1938046/000149315223045420/0001493152-23-045420-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Boustead Securities, LLC, as representative of the underwriters"},{"label":"Value","value":"$1.2 million"},{"label":"Effective","value":"2023-12-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}